2016 Fiscal Year Final Research Report
Trials to treat progressive MS
| Project/Area Number |
26461293
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Neurology
|
|---|
| Research Institution | Osaka University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
Hideki Mochizuki 大阪大学, 医学系研究科, 教授 (90230044)
Atsuhi Kumanogoh 大阪大学, 医学系研究科, 教授 (10294125)
|
|---|
| Project Period (FY) |
2014-04-01 – 2017-03-31
|
| Keywords | 多発性硬化症 / 筋萎縮性側索硬化症 / Sema3E / 虚血 / 低酸素 |
|---|
| Outline of Final Research Achievements |
Multiple Sclerosis(MS) and Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by the pathogenesis of which includes ischemia and hypoxia. However, the precise role of hypoxia in neurodegenerative diseases remains unknown. In this study, we administered a synthetic prostacyclin agonist ONO1301, to animal model of ALS (mSOD1G93A mice) to alleviate ischemia and hypoxia in the spinal cord. Prostacyclin agonist successfully suppressed the expression level of HIF1-αin the spinal cords of mSOD1G93A mice, resulting in the significant prevention of neurodegeneration. Our data is the first documented study to suggest that blood flow increasing therapy has a potential to improve neurodegenrative diseases.
|
| Free Research Field |
神経免疫学
|
